Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 11, 2025Journal of Clinical MedicineOpen Access

New Frontiers of microRNA in Heart Failure: From Clinical Risk to Therapeutic Applications

View Full Paper
Ask AI
Bookmark
Share

Authors

IFIsabella FumaruloAPAndrea De PriscoESEdward Salerno

Discussion

Loading...

Member takes

Overview

Review analyzes microRNA's potential in heart failure as biomarkers and therapeutic targets, suggesting strategies for modulating expression.

Key Points

  • MicroRNAs play a crucial role in heart failure, influencing fibrosis and inflammation.
  • Emerging as biomarkers, microRNAs could enable non-invasive diagnosis and prognostic stratification.
  • Therapeutic targeting of microRNAs may offer new avenues for heart failure treatment.
  • Continuous advancements in heart failure management necessitate innovative approaches, particularly in biomarker and therapeutic discovery.

Cite This Study

Fumarulo et al. (2025) studied this question.

synapsesocial.com/papers/68d41734713b0b5dfea63858https://doi.org/10.3390/jcm14186361
View Full Paper
Ask AI
Bookmark
Share